New Protein Fund
-
DATABASE (727)
-
ARTICLES (735)
Global Investment Fund (GIF) is an impact investment fund supporting new ventures that are solving social problems in the developing world. Besides investing through debt, equity investments and SAFE (simple agreement for future equity) contracts, GIF also disburses grants for social enterprises. It invests in various sectors, including agriculture and aquaculture, health, education, water and fintech.
Global Investment Fund (GIF) is an impact investment fund supporting new ventures that are solving social problems in the developing world. Besides investing through debt, equity investments and SAFE (simple agreement for future equity) contracts, GIF also disburses grants for social enterprises. It invests in various sectors, including agriculture and aquaculture, health, education, water and fintech.
Chairman of the Board, co-founder, co-inventor of NovoNutrients
Russell J. Howard has been co-founder and chairman of the board at NovoNutrients, a San Francisco biotech manufacturer of alt-protein produced using fermentation and CO2, and the research company Oakbio, since the latter’s foundation in 2009. During this period, for a year, Howard also worked as head of commercial strategy at Genome.One, a genetics startup. Howard is also on the board of executives of two Australian pharma companies, Immutep and NeuClone. Previously, between 1997 and 2009, he was CEO at California-based Maxygen, dedicated to the commercialization of molecular breeding and gene shuffling in protein. The year before that, Howard was president and scientific director at global pharma giant GSK in Santa Clara, and between 1994 and 1996, he held the same position at AFFYMAX Research Institute, working on new drugs research. Howard also held long-term research positions, heading up the laboratory at Palo Alto’s DNAX Research Institute of Molecular & Cellular Biology for six years, and earlier spent nine years at Bethesda’s National Institute of Allergy and Infectious Diseases (NIAID) working on identifying new malarial pathogens. The doctor of biochemistry from the University of Melbourne has over 140 peer-reviewed publications. Following his studies, Howard spent three years undertaking postdoctoral research at Australia’s WEHI (formerly the Walter and Eliza Hall Institute of Medical Research).
Russell J. Howard has been co-founder and chairman of the board at NovoNutrients, a San Francisco biotech manufacturer of alt-protein produced using fermentation and CO2, and the research company Oakbio, since the latter’s foundation in 2009. During this period, for a year, Howard also worked as head of commercial strategy at Genome.One, a genetics startup. Howard is also on the board of executives of two Australian pharma companies, Immutep and NeuClone. Previously, between 1997 and 2009, he was CEO at California-based Maxygen, dedicated to the commercialization of molecular breeding and gene shuffling in protein. The year before that, Howard was president and scientific director at global pharma giant GSK in Santa Clara, and between 1994 and 1996, he held the same position at AFFYMAX Research Institute, working on new drugs research. Howard also held long-term research positions, heading up the laboratory at Palo Alto’s DNAX Research Institute of Molecular & Cellular Biology for six years, and earlier spent nine years at Bethesda’s National Institute of Allergy and Infectious Diseases (NIAID) working on identifying new malarial pathogens. The doctor of biochemistry from the University of Melbourne has over 140 peer-reviewed publications. Following his studies, Howard spent three years undertaking postdoctoral research at Australia’s WEHI (formerly the Walter and Eliza Hall Institute of Medical Research).
The municipal government of Wuhan launched Wuhan S&T Angel Venture Fund in September 2013. With RMB 300 million under management, the fund is operated by Wuhan S&T Angel Venture Fund Management Co., Ltd. It invests mainly in the information technology, new materials, advanced equipment manufacturing, biomedicine, new energy, automotive, energy conservation, environmental protection and modern agriculture fields.
The municipal government of Wuhan launched Wuhan S&T Angel Venture Fund in September 2013. With RMB 300 million under management, the fund is operated by Wuhan S&T Angel Venture Fund Management Co., Ltd. It invests mainly in the information technology, new materials, advanced equipment manufacturing, biomedicine, new energy, automotive, energy conservation, environmental protection and modern agriculture fields.
Hengqin CIMC Readysun Innovation & Entrepreneurship Investment Fund
Hengqin CIMC Readysun Innovation & Entrepreneurship Investment Fund is a VC fund set up by China International Marine Containers (CIMC) and Shenzhen Readysun Investment Group on June 14, 2017. The fund focuses on fast-growing high-end equipment manufacturing and new technology sectors, such as intelligent logistics, industrial automation and robots, industrial internet, green new materials.
Hengqin CIMC Readysun Innovation & Entrepreneurship Investment Fund is a VC fund set up by China International Marine Containers (CIMC) and Shenzhen Readysun Investment Group on June 14, 2017. The fund focuses on fast-growing high-end equipment manufacturing and new technology sectors, such as intelligent logistics, industrial automation and robots, industrial internet, green new materials.
Founded by Wen Yunsong (Winston Wen), son of former Chinese premier Wen Jiabao, and Yu Jianming in 2005, New Horizon is a private equity firm focused on advanced manufacturing, alternative energy, consumer products and services, and healthcare.
Founded by Wen Yunsong (Winston Wen), son of former Chinese premier Wen Jiabao, and Yu Jianming in 2005, New Horizon is a private equity firm focused on advanced manufacturing, alternative energy, consumer products and services, and healthcare.
Head of Research, co-founder of Xampla
Marc Rodríguez Garcia is Head of Research and co-founder of Britain’s Xampla, producer of plant-based biodegradable plastics made from protein, where he has worked full-time since it was founded in 2018. Prior to that, from late 2016 he was a postdoctoral research associate at Cambridge University’s Knowles Lab, from which Xampla was spun off. The Spaniard has also worked as a visiting researcher for the not-for-profit Cancer Research UK.Rodríguez holds a PhD from the University of Glasgow, developing a new method to synthesize oligopeptides from unactivated amino acids, and a bachelor’s degree in chemistry from the Autonomous University of Barcelona.
Marc Rodríguez Garcia is Head of Research and co-founder of Britain’s Xampla, producer of plant-based biodegradable plastics made from protein, where he has worked full-time since it was founded in 2018. Prior to that, from late 2016 he was a postdoctoral research associate at Cambridge University’s Knowles Lab, from which Xampla was spun off. The Spaniard has also worked as a visiting researcher for the not-for-profit Cancer Research UK.Rodríguez holds a PhD from the University of Glasgow, developing a new method to synthesize oligopeptides from unactivated amino acids, and a bachelor’s degree in chemistry from the Autonomous University of Barcelona.
CreditEase New Financial Industry Investment Fund
Credit Ease Financial Industry Investment Fund was founded in 2016 and now manages a combined total of RMB 3 billion and US$ 500 million. It has invested in more than 20 Fintech companies around the world.
Credit Ease Financial Industry Investment Fund was founded in 2016 and now manages a combined total of RMB 3 billion and US$ 500 million. It has invested in more than 20 Fintech companies around the world.
Nutrinsect’s cricket flour is a 100% organic alternative protein containing twice the protein of soy, with an all-purpose natural fertilizer as its byproduct.
Nutrinsect’s cricket flour is a 100% organic alternative protein containing twice the protein of soy, with an all-purpose natural fertilizer as its byproduct.
With a 55-tone capacity to produce fungi-based proteins annually, Mycorena’s Gothenburg facility will showcase its mycoprotein R&D and spur commercial expansion across Europe.
With a 55-tone capacity to produce fungi-based proteins annually, Mycorena’s Gothenburg facility will showcase its mycoprotein R&D and spur commercial expansion across Europe.
E²JDJ was founded in New Orleans in 2020 with an agtech and foodtech focus, including in the areas of cellular agriculture and synthetic biology. It has six startups in its portfolio and makes diverse investments. Its most recent disclosed investment was in the $4.7m July 2021 seed funding round of NovoNutrients, the US-based biotech producer of alt-protein from fermentation using CO2 and other emissions.
E²JDJ was founded in New Orleans in 2020 with an agtech and foodtech focus, including in the areas of cellular agriculture and synthetic biology. It has six startups in its portfolio and makes diverse investments. Its most recent disclosed investment was in the $4.7m July 2021 seed funding round of NovoNutrients, the US-based biotech producer of alt-protein from fermentation using CO2 and other emissions.
The Alexa Fund provides up to $200 million in venture capital funding to fuel voice technology innovation. It is focused on how voice technology can improve customers’ lives, from early-stage pre-revenue companies to established brands. Areas of particular interest include: hardware products that would benefit from the Alexa Voice Service; skills that deliver new abilities to Alexa-enabled devices through the Alexa Skills Kit; and new contributions to the science behind voice technology, including text to speech, natural language understanding, automatic speech recognition, artificial intelligence and hardware component design.
The Alexa Fund provides up to $200 million in venture capital funding to fuel voice technology innovation. It is focused on how voice technology can improve customers’ lives, from early-stage pre-revenue companies to established brands. Areas of particular interest include: hardware products that would benefit from the Alexa Voice Service; skills that deliver new abilities to Alexa-enabled devices through the Alexa Skills Kit; and new contributions to the science behind voice technology, including text to speech, natural language understanding, automatic speech recognition, artificial intelligence and hardware component design.
Co-founder of Mapan by Ruma
After graduating with an Industrial Engineering degree from Purdue University in the US, Sean DeWitt became a management consultant at PricewaterhouseCoopers. He later worked at the US Department of State and the Fund for New York City.In 2007, he joined the nonprofit Grameen Foundation that was established by Grameen Bank founder Muhammad Yunus. As part of the nonprofit, he helped Aldi Haryopratomo establish the social enterprise Ruma. DeWitt currently works for the World Resource Institute. He also holds master’s degrees in Development Finance and Environmental Economics from the University of London.
After graduating with an Industrial Engineering degree from Purdue University in the US, Sean DeWitt became a management consultant at PricewaterhouseCoopers. He later worked at the US Department of State and the Fund for New York City.In 2007, he joined the nonprofit Grameen Foundation that was established by Grameen Bank founder Muhammad Yunus. As part of the nonprofit, he helped Aldi Haryopratomo establish the social enterprise Ruma. DeWitt currently works for the World Resource Institute. He also holds master’s degrees in Development Finance and Environmental Economics from the University of London.
New York-based Humboldt Fund invests in startups with the potential to solve critical issues of our time across the areas of food production, healthcare, energy, and construction and manufacturing materials. It currently has 14 companies in its portfolio. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the February 2021 $16m seed round of US biotech Cellino Biotech.
New York-based Humboldt Fund invests in startups with the potential to solve critical issues of our time across the areas of food production, healthcare, energy, and construction and manufacturing materials. It currently has 14 companies in its portfolio. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the February 2021 $16m seed round of US biotech Cellino Biotech.
Co-founder of Xampla
Tuomas Knowles is co-founder of Britain’s Xampla, producer of plant-based biodegradable plastics made from protein, which was founded in 2018 based on his team’s pioneering research. Knowles is a professor of physical chemistry and biophysics at Cambridge University, where he has worked since 2010 and manages the Knowles Lab which focuses on researching protein self-assembly underlying neurodegenerative disorders like Alzheimer's and Parkinson's disease. Knowles holds a PhD in Biophysics from the University of Cambridge and a degree in physics from ETH Zurich, a science and technology university.
Tuomas Knowles is co-founder of Britain’s Xampla, producer of plant-based biodegradable plastics made from protein, which was founded in 2018 based on his team’s pioneering research. Knowles is a professor of physical chemistry and biophysics at Cambridge University, where he has worked since 2010 and manages the Knowles Lab which focuses on researching protein self-assembly underlying neurodegenerative disorders like Alzheimer's and Parkinson's disease. Knowles holds a PhD in Biophysics from the University of Cambridge and a degree in physics from ETH Zurich, a science and technology university.
Vostok New Ventures is a Swedish investment company that invests globally in companies with network effects, founded in 2007. It has a special focus on the areas of real estate, recruitment and job sites, travel and transportation services and general classified ads. It participates in growth-stage companies and has invested in 27 companies, 18 of which as leading investor. Its exits are Avito, Quandoo and Delivery Hero.
Vostok New Ventures is a Swedish investment company that invests globally in companies with network effects, founded in 2007. It has a special focus on the areas of real estate, recruitment and job sites, travel and transportation services and general classified ads. It participates in growth-stage companies and has invested in 27 companies, 18 of which as leading investor. Its exits are Avito, Quandoo and Delivery Hero.
Big Idea Ventures Founder Andrew D Ive: Asia will lead cell-based meat innovation
In a wide-ranging interview, the managing general partner of the US- and Singapore-based foodtech investor also expounds on his goal to extend sustainability to the rest of the food sector, combining good returns with doing good
New Food Invest: Growing an alternative protein business in Asia
With more than 4bn people, Asia presents unique opportunities and challenges to alternative protein startups. Four leading entrepreneurs shared their experiences at the recent New Food Invest conference
New Food Invest: Challenges of growing an alt-protein startup
Founders of three alt-protein startups in the US share what motivated them to start, their personal experiences growing the businesses, getting funding and finding strategic partners
New Food Invest: Opportunities in the European alt-protein space
With a record €2.4bn investment in 2019, Europe’s foodtech sector appears poised for continued growth, but startups, corporations, governments and even universities can do more, experts say
Dao Foods: Grooming and betting on China's rising alternative protein startups
How can businesses involve Chinese consumers in the environmental cause, even if it isn’t a priority for them? For that, the impact investor-incubator Dao Foods has got its philosophy-led strategy figured out
Indogen Capital eyes new growth fund of $100m as foreign tech investors stay keen on Indonesia
With its Japanese investment partner Striders, Indogen plans to boost growth-stage funding in Indonesia and open doors for portfolio companies to new markets in East Asia
Good Startup: Alt-protein products can be better than real meat
The investor of Eat Just, Ripple Foods and more expects its portfolio companies will exit in the next four to six years, mostly through acquisition
NovoNutrients: Tackling the dual problems of CO2 emissions and over-fishing
The first to transform CO2 to fish food, NovoNutrients is trialing with industry giants Skretting and Chevron, and will soon raise Series A funding
New Food Invest: Plant-based cheese, the next investment boom?
With alt-protein startups experiencing a global funding boom, industry experts and investors share their views about emerging trends in diverse food sectors
Plant-based meat faces backlash in China despite gaining traction
An innocuous video clip sparked debate on social media over plant-based meat, with suspicion about its nutritional value, cost-effectiveness and even the motives of foreign companies
String Bio: Asia's first startup to harness methane gas for protein production
Using bacteria to turn the harmful greenhouse gas into a purer form of protein, String Bio is raising Series B funding to scale production
Mycorena: Fungi-based vegan protein challenging traditional plant-based ingredients
Award-winning Swedish biotech startup is scaling production of mycoprotein to become a key player in the emerging market for functional proteins
Oceanium: Supporting sustainable seaweed farming
Scottish startup Oceanium has developed a proprietary biorefinery and processing model to create seaweed-based compostable materials, alt-protein ingredients and nutraceuticals for use across industry verticals
Heura by Foods for Tomorrow: Another new kid on the multibillion-dollar alternative protein market
Already selling in nine countries, Heura’s recent entry into the UK, Europe's largest market for meat substitutes, could prove its biggest test to date
Xampla: Making strong, low-cost biodegradable plastic from peas
Inspired by the strength of spider silk, the Cambridge University spinoff has produced a plant-based, completely compostable alternative to microplastics
Sorry, we couldn’t find any matches for“New Protein Fund”.
POPULAR DATABASE
